Balversa Drug Interactions: 187 Major, 364 Moderate
Balversa (Erdafitinib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Balversa. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Erdafitinib.
Level 1 evidence
Acalabrutinib
The serum concentration of Acalabrutinib can be increased when it is combined with Erdafitinib.
Level 1 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Erdafitinib.
Level 1 evidence
Acoramidis
The serum concentration of Erdafitinib can be increased when it is combined with Acoramidis.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Erdafitinib.
Level 1 evidence
Albendazole
The metabolism of Erdafitinib can be decreased when combined with Albendazole.
Level 2 evidence
Alectinib
The serum concentration of Alectinib can be increased when it is combined with Erdafitinib.
Level 1 evidence
Almasilate
The risk or severity of adverse effects can be increased when Almasilate is combined with Erdafitinib.
Level 1 evidence
Alpelisib
The metabolism of Erdafitinib can be increased when combined with Alpelisib.
Level 1 evidence
Aluminium phosphate
The risk or severity of adverse effects can be increased when Aluminium phosphate is combined with Erdafitinib.
Level 1 evidence
Aluminum hydroxide
The risk or severity of adverse effects can be increased when Aluminum hydroxide is combined with Erdafitinib.
Level 1 evidence
Amantadine
The serum concentration of Amantadine can be increased when it is combined with Erdafitinib.
Level 2 evidence
Enter your NPI to unlock 27 major interactions for Balversa
Balversa (Erdafitinib) has 638 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Balversa (Erdafitinib) has 187 major, 364 moderate, and 87 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Balversa. Always confirm against the full prescribing information.